FDA official logo
GSRS logo
PFDA official logo

RIVASTIGMINE TARTRATE

  • UNII: 9IY2357JPE
  • Formula: C14H22N2O2.C4H6O6
  • Preferred Substance Name: RIVASTIGMINE TARTRATE
  • InChIKey: GWHQHAUAXRMMOT-MBANBULQSA-N

  • 129101-54-8
  • CARBAMIC ACID, N-ETHYL-N-METHYL-, 3-((1S)-1-(DIMETHYLAMINO)ETHYL)PHENYL ESTER, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)
  • ENA 713
  • ENA-713
  • RIVASTIGMINE (AS HYDROGEN TARTRATE)
  • RIVASTIGMINE ACTAVIS
  • RIVASTIGMINE BITARTRATE
  • RIVASTIGMINE HYDROGEN TARTRATE
  • RIVASTIGMINE HYDROGEN TARTRATE [EMA EPAR]
  • RIVASTIGMINE HYDROGEN TARTRATE [EP MONOGRAPH]
  • RIVASTIGMINE HYDROGEN TARTRATE [MART.]
  • RIVASTIGMINE HYDROGEN TARTRATE [MI]
  • RIVASTIGMINE HYDROGEN TARTRATE [WHO-DD]
  • RIVASTIGMINE HYDROGENTARTRATE
  • RIVASTIGMINE TARTRATE [ORANGE BOOK]
  • RIVASTIGMINE TARTRATE [USP MONOGRAPH]
  • RIVASTIGMINE TARTRATE [USP-RS]
  • RIVASTIGMINE TARTRATE [VANDF]
  • SDZ-ENA 713
  • SDZ-ENA-713

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.